The Role of Endoplasmic Reticulum Stress in Type 1 Diabetes: Identification of Glucose Regulated Protein 78 As the Autoantigen for Bdc-2.5 T Cell Clone
Total Page:16
File Type:pdf, Size:1020Kb
THE ROLE OF ENDOPLASMIC RETICULUM STRESS IN TYPE 1 DIABETES: IDENTIFICATION OF GLUCOSE REGULATED PROTEIN 78 AS THE AUTOANTIGEN FOR BDC-2.5 T CELL CLONE. by Sheila Marie Schreiner B.S., Bridgewater State College, 2002 Submitted to the Graduate Faculty of School of Medicine in partial fulfillment of the requirements for the degree of Doctor of Philosophy University of Pittsburgh 2007 UNIVERSITY OF PITTSBURGH THE SCHOOL OF MEDICINE This dissertation was presented by Sheila Marie Schreiner It was defended on November 6th 2007 and approved by Nick Giannoukakis PhD Assistant Professor, Cellular and Molecular Pathology Tim D. Oury MD/PhD Associate Professor, Cellular and Molecular Pathology Massimo Trucco MD Hillman Professor of Pediatric Immunology Division Head of Immunogenetics, Immunology Committee Chair: Wendy M. Mars PhD Associate Professor, Cellular and Molecular Pathology Thesis Director: Jon D. Piganelli PhD Assistant Professor, Cellular and Molecular Pathology ii THE ROLE OF ENDOPLASMIC RETICULUM STRESS IN TYPE 1 DIABETES: IDENTIFICATION OF GLUCOSE REGULATED PROTEIN 78 AS THE AUTOANTIGEN FOR BDC-2.5 T CELL CLONE. Sheila Marie Schreiner, PhD University of Pittsburgh, 2007 Environmental triggers, such as viral infection and environmental toxins, have been proposed to initiate the autoimmune disease of Type 1 Diabetes (T1D), however, the mechanism is unknown. The identification of novel autoantigens may provide insight to the mechanism of environmental triggers and pathogenesis of T1D. I identified the antigen recognized by the diabetogenic BDC- 2.5 T cell clone using a novel in vivo reconstitution system, Restricted Immune System via Adoptive Transfer (RISAT). In RISAT, immunodeficient mice are adoptive transferred with a single T cell clone and an open repertoire of B cells. Reconstituted mice are immunized with an antigenic protein preparation. This system will drive an antibody response to the cognate antigen for the T and B cell through the co-stimulatory pathways involved in linked recognition. For the BDC-2.5 RISAT, non-obese diabetic (NOD).Rag-/- mice were adoptive transferred with the diabetogenic BDC-2.5 T cells and NOD B cells and then immunized with an antigenic beta cell membrane preparation (βmem) to drive an antibody response. The resulting antibodies recognized the endoplasmic reticulum (ER) stress associated protein glucose regulated protein 78 (GRP78) from βmem. To determine if ER stress plays a role in the antigenic response of the BDC-2.5 T cell clone, the non-antigenic NOD insulinoma cell line, NIT-1, were treated with thapsigargin, which induces ER stress. The treatment of NIT-1 with thapsigargin led to increased GRP78 synthesis, correlating with antigenic recognition by the BDC-2.5 T cell clone. iii The antibodies from the BDC-2.5 TCR-Tg recognizes a subset of GRP78 which is modified with phosphoserine. The data presented in this thesis demonstrates a mechanistic link between ER stress and environmental triggers leading to the initiation of TID through the novel autoantigen, GRP78. Also the technique, RISAT, can be used to identify additional potential autoantigens of isolated T cell clones in both T1D and other autoimmune diseases. iv TABLE OF CONTENTS PREFACE............................................................................................................................ XIV 1.0 INTRODUCTION ........................................................................................................... 1 1.1 DIABETES & GLUCOSE METABOLISM........................................................... 1 1.2 NON-AUTOIMMUNE DIABETES........................................................................ 3 1.3 TYPE 1 DIABETES................................................................................................. 4 1.3.1 Insulin Replacement Therapy ...................................................................... 5 1.3.2 Islet Replacement Therapy........................................................................... 6 1.4 GENETICS OF TYPE 1 DIABETES ..................................................................... 7 1.4.1 HLA Susceptibility........................................................................................ 7 1.4.2 Non-MHC Genes........................................................................................... 8 1.5 ENIVRONMENTAL FACTORS............................................................................ 9 1.5.1 Viral Infections ............................................................................................. 9 1.5.2 Noninfectious Environmental Triggers...................................................... 10 1.6 IMMUNOLOGY OF TYPE 1 DIABETES........................................................... 11 1.6.1 Central Tolerance ....................................................................................... 13 1.6.1.1 Principles of clonal deletion............................................................. 13 1.6.2 Peripheral Tolerance .................................................................................. 15 1.6.2.1 Clonal Anergy and Adaptive Tolerance.......................................... 15 v 1.6.2.2 Regulation. ....................................................................................... 16 1.6.2.3 Ignorance. ........................................................................................ 17 1.6.3 Acquired Tolerance .................................................................................... 17 1.7 B CELL DEVELOPMENT AND ANTIBODY MATURATION........................ 17 1.8 AUTOIMMUNITY: BREAKDOWN OF THE IMMUNE SYSTEM.................. 20 1.9 AUTOANTIBODIES & AUTOANTIGENS ASSOCIATED WITH T1D .......... 20 1.9.1 Glutamic Acid Decarboxylase (GAD65) .................................................... 22 1.9.2 Insulinoma-associated protein 2 (IA-2)...................................................... 22 1.9.3 Insulin.......................................................................................................... 23 1.9.4 Islet Cell Autoantigen of 69 kDA (ICA69) ................................................. 24 1.9.5 Other autoantigens ..................................................................................... 25 1.9.5.1 Heat shock protein 70 (HSP70). ...................................................... 27 1.9.5.2 Islet-specific Glucose-6-phosphatase catalytic subunit-Related Protein (IGRP). .............................................................................................. 27 1.10 TYPE 1 DIABETES MOUSE MODEL .............................................................. 28 1.10.1 Non-Obese Diabetic (NOD) Mouse Model............................................... 28 1.10.2 BDC-2.5 T Cell Clone ............................................................................... 29 1.10.3 BDC-2.5 TCR-Transgenic Mouse Model................................................. 31 1.11 PROTEIN TRAFFICKING ................................................................................ 33 1.12 ENDOPLASMIC RETICULUM STRESS PATHWAY .................................... 34 1.12.1 Unfolded Protein Response (UPR)........................................................... 36 1.12.2 Translational attenuation ......................................................................... 36 1.12.3 ER associated degradation ...................................................................... 37 vi 1.12.4 ER stress-apoptosis ................................................................................... 37 1.13 ER STRESS AND THE BETA CELL ................................................................ 38 1.14 ER STRESS AND DISEASE............................................................................... 39 2.0 HYPOTHESIS AND SPECIFIC AIMS........................................................................ 40 3.0 MATERIALS AND METHOD ..................................................................................... 41 3.1 ANIMALS.............................................................................................................. 41 3.2 T- AND B-CELL ISOLATION, T CELL CLONE CULTURE, AND ANTIGEN- SPECIFIC T CELL ASSAY. ......................................................................................... 41 3.3 RISAT RECONSTITUTION VIA ADOPTIVE TRANSFERS, IMMUNIZATION, AND SERA COLLECTION. ........................................................ 42 3.4 IMMUNOBLOT ANALYSIS................................................................................ 43 3.5 SCREENING SERUM FOR AUTOANTIBODIES ............................................. 44 3.6 IMMUNOPRECIPITATION OF AUTOANTIGENS ......................................... 45 3.7 PROTEOMIC ASSAYS FOR IDENTIFICATION OF CANDIDATE AUTOANTIGEN............................................................................................................ 45 3.8 INDUCTION AND DETECTION OF ER STRESS AND/OR APOPTOSIS IN CELL LINES.................................................................................................................. 46 3.9 GRP78 PEPTIDE LIBRARY................................................................................ 47 3.10 ATP 8-AH SEPHAROSE PURIFICATION OF GRP78 ................................... 48 3.11 REMOVAL OF O-LINKED GLYCOSYLATION ............................................ 48 3.12 CITRULLINATION DETECTION ASSAY ...................................................... 49 4.0 GLUCOSE REGULATED PROTEIN 78 (GRP78): A CANDIDATE ANTIGEN FOR THE DIABETOGENIC T CELL CLONE, BDC-2.5...........................................................